Social Media Ideas for Buy-And-Bill

The IRA Fixed One Medicare Part D Distortion—But Patients Now Face New Tradeoffs

By Bryce Platt, PharmD For years, Medicare Part D plans often preferred high-list/high-rebate branded multiple sclerosis (MS) drugs over lower-cost generics. That was rational b...

Medicare Embraces Site-Neutral Payments. Why Haven't Employers?

By Bryce Platt, PharmD Provider-administered drugs are one of the fastest-growing and least-managed cost drivers for commercial plan sponsors. Despite that, recent data from...

The Future of 340B: New Bills Offer Competing Solutions to Modernize the 340B Drug Discount Program

CMS Codifies Drug Price Negotiation Program—With Modifications for 2029

On June 16, 2025, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule, “Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Pro...

The Hidden Cost of 340B for Employers and Health Plans

By Adam J. Fein, Ph.D.For years, the controversy surrounding the 340B Drug Pricing Program has centered on hospitals, manufacturers, and contract pharmacies. But employers and h...

The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs

By Adam J. Fein, Ph.D. and Greis Kapexhiu It’s time for Drug Channels Institute’s latest exclusive analysis of the 340B contract pharmacy market, which continues to boom along with...

Cassidy's new plan to overhaul 340B: Rebates, contract pharmacy limits and more changes

A legislative discussion draft shared Thursday by the Senate HELP chairman includes rebates, contract pharmacy limits, narrowed definitions and other proposals.

<![CDATA[An End-to-End Approach to Specialty Patient Services]]>

Drugs, Discounts and Data: Crafting Sustainability in an Imperfect System

Today’s guest post comes from Angie Franks, Chief Executive Officer at Kalderos. As Angie explains, the industry still lacks the transparency needed to effectively manage where d...

Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.

WEDNESDAY, July 8, 2026 — For 16 years, Larry Gruber, a fitness coach from Wilton Manors, Florida, received a coupon card to help him pay for a psoriatic arthritis medication he ne...

White House adds 600 generic meds to TrumpRx purchasing portal

With questions already swirling about the actual affordability impact of the government’s drug purchasing portal TrumpRx, the White House is updating the platform to address a key...

New Proposal Signals Big Changes Ahead for Embattled Drug Discount Program

“The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual relationships, and compliance programs if these reforms advance,...

Drug Channels News Roundup, June 2026: PBM Shakeout Accelerates, 340B Enters a New Era, Rebate Questions Persist, Mark C...

Happy 250th birthday, America! Before you launch your semiquincentennial festivities, Drug Channels offers some fireworks of our own: The PBM Shakeout Is Gaining Momentum 340B:...

GoodRx launches subscription program for low-cost generic medications, telehealth services

Users can access discounted medications, telehealth care and other savings through the $14.99 per-month subscription service.

<![CDATA[The Economics of the 340B Drug Pricing Program: Strategic Imperatives for the Life Sciences Industry in 2026...

Democrats to propose bill capping out-of-pocket costs for Medicare enrollees

Sen. Ron Wyden and 14 Democratic co-sponsors plan to introduce legislation Thursday to cap consumers’ potential out-of-pocket costs in traditional Medicare, resurfacing a long-runn...

What to know about the temporary Medicare GLP-1 Bridge program

Starting in July, some Medicare beneficiaries will be able to access GLP-1 medications by paying one flat fee per month. The temporary program is set to run for a year-and-a-half t...

Bipartisan bill would force insurers and PBMs to divest pharmacies

Sweeping new proposal targets vertically integrated giants – and the clock could start ticking within a year

<![CDATA[TrumpRx Expands to Offer Generic Medications]]>

<![CDATA[CVS Restores Coverage of Lilly’s Zepbound, Adds Oral Obesity Drug Foundayo]]>

Canadians can now get digital prescriptions for 'generic Ozempic'

Hims & Hers has started offering eligible customers personalized treatment plans starting at $149/month

The 340B Program Hit $100 Billion in 2025: Has It Become Too Big to Reform?

By Adam J. Fein, Ph.D.The 340B Drug Pricing Program continues to redefine the meaning of "skyrocketing." For 2025, discounted purchases under the 340B program reached an astound...

McDermott+ Check-Up: June 18, 2026

THIS WEEK’S DOSE Senate Democrats request information on reforming drug pricing. The request for information focuses on lowering prescription drug pricing and out-of-pocket costs...

Senate and House Lawmakers Unveil Competing 340B Reform Proposals

By Abdie Santiago —